John Steiner to Antihypertensive Agents
This is a "connection" page, showing publications John Steiner has written about Antihypertensive Agents.
Connection Strength
1.719
-
Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):645-53.
Score: 0.370
-
Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012 Jan; 27(1):57-64.
Score: 0.347
-
Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009 Sep; 2(5):451-7.
Score: 0.301
-
Hypertension care during the COVID-19 pandemic in an integrated health care system. J Clin Hypertens (Greenwich). 2023 Apr; 25(4):315-325.
Score: 0.193
-
Effect of Values Affirmation on Reducing Racial Differences in Adherence to Hypertension Medication: The HYVALUE Randomized Clinical Trial. JAMA Netw Open. 2021 12 01; 4(12):e2139533.
Score: 0.177
-
Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015 Apr; 53(4):332-7.
Score: 0.111
-
An investigation of associations between clinicians' ethnic or racial bias and hypertension treatment, medication adherence and blood pressure control. J Gen Intern Med. 2014 Jul; 29(7):987-95.
Score: 0.103
-
Gender differences in cardiovascular risk factors in incident diabetes. Womens Health Issues. 2014 Jan-Feb; 24(1):e61-8.
Score: 0.102
-
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006 Sep 25; 166(17):1836-41.
Score: 0.015